What is the estimated value of this tender?

The estimated value published by the buyer is €1.

Who is the buyer of this tender?

The contracting authority is DAK-Gesundheit (European Union).

Awarded European Union

Arzneimittelrahmenrabattvertrag gemäß § 130a Absatz 8 bzw. § 130c Abs. 1 des Fünften Sozialgesetzbuchs - Ebglyss (Wirkstoff: Lebrikizumab), ATC D11AH10

Buyer: DAK-Gesundheit

Open in El Vínculo

Published: 24 January 2024
Estimated value: €1
Place of performance: DE600
Procedure: neg-wo-call
Lots: 1
Notice number: 00049439-2024
Reference: b7268c39-073c-4c36-941f-7f226ed672df
Official source: Official source

CPV codes

33600000Productos farmacéuticos

Description

Gegenstand dieses Vertrags ist die Vereinbarung von Rabattzahlungen gemäß § 130a Abs. 8 bzw. § 130c Abs. 1 SGB V auf das Arzneimittel Ebglyss (Wirkstoff: Lebrikizumab), das von Almirall Hermal GmbH vertrieben und zu Lasten der DAK-G verordnet wird. Von dieser Vereinbarung erfasst wird das Arzneimittel Ebglyss in verfügbaren Wirkstärken, Darreichungsformen und Packungsgrößen.

Awards

Awarded to	Amount	Date
Renn Architekten	—	—

Frequently asked questions

What is the estimated value of this tender?: The estimated value published by the buyer is €1.
Who is the buyer of this tender?: The contracting authority is DAK-Gesundheit (European Union).

Get alerts for tenders like this
Create a free account and receive new tenders from European Union matching your business, every day.

Start for free

Data collected from official public procurement sources. Amounts as published by the buyer.